Regn investors have opportunity to lead regeneron pharmaceuticals, inc. securities fraud lawsuit

New york , jan. 27, 2025 /prnewswire/ -- rosen law firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of regeneron pharmaceuticals, inc. (nasdaq: regn) between november 2, 2023 and october 30, 2024, both dates inclusive (the "class period"). a class action lawsuit has already been filed.

REGN Ratings Summary

REGN Quant Ranking